Pay in 4 interest-free payments of $7.37 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
In the UK, different GLP-1 receptor agonists have specific licensed indications: For type 2 diabetes : semaglutide (Ozempic), dulaglutide (Trulicity), and liraglutide (Victoza) For weight management : semaglutide 2.4mg (Wegovy) and liraglutide 3.0mg (Saxenda) NICE guideline NG28 recommends GLP-1 receptor agonists as treatment options for type 2 diabetes when first-line therapies have not achieved adequate glycaemic control
How nasal peptide absorption works The science behind intranasal peptide delivery involves understanding what happens when a peptide solution contacts your nasal mucosa
+ Side effects are rare
Michael, 38, BMI 34, no diabetes : Michaels physician discussed both Wegovy and Zepbound for weight management
Injection site pain or redness is the most common complaint
US$ 20.33
US$ 27.08
US$ 23.89
US$ 20.49
US$ 24.71
